ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Drugs for Neglected Diseases initiative
A Dengue Programme Leader at DNDi drives the scientific and strategic development of the Dengue program, overseeing preclinical and clinical activities globally and regionally, ensuring alignment with the organization's R&D strategy and effective collaboration with internal and external partners.
DNDi (Drugs for Neglected Diseases initiative) is a non-profit research and development organization developing affordable, life-saving medicines for neglected diseases. Since 2003, DNDi has delivered 14 treatments for 6 deadly diseases, working in open partnerships with academia, industry and endemic-country networks to ensure access and public-health impact.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Drugs for Neglected Diseases initiative.
Drugs for Neglected Diseases initiative didn’t post a salary, so this is our estimate from similar listings.
Associate, Dengue Program
Clinton Health Access Initiative
Dengue Manager, Asia
Clinton Health Access Initiative
Senior Associate, Dengue - Guatemala
Clinton Health Access Initiative
R&D Project Manager
Elanco
Preclinical Programme Leader, Cardiovascular & Metabolic Diseases
ASTARPRD
Director of Preclinical & Clinical Science
Wellfound